Posted by Michael Wonder on 14 Mar 2021
Choosing the right director for the U.S. Patent and Trademark Office can help lower drug prices
12 March 2021 - As the Biden administration fills key Cabinet positions, its attention must turn to other critical areas of the U.S. government, like appointing a new director of the U.S. Patent and Trademark Office.
This agency is unusual in the federal government because it operates solely on fees collected by its users and not on taxpayer dollars.
